Literature DB >> 23464991

Drafting the CLN3 protein interactome in SH-SY5Y human neuroblastoma cells: a label-free quantitative proteomics approach.

Enzo Scifo1, Agnieszka Szwajda, Janusz Dębski, Kristiina Uusi-Rauva, Tapio Kesti, Michał Dadlez, Anne-Claude Gingras, Jaana Tyynelä, Marc H Baumann, Anu Jalanko, Maciej Lalowski.   

Abstract

Neuronal ceroid lipofuscinoses (NCL) are the most common inherited progressive encephalopathies of childhood. One of the most prevalent forms of NCL, Juvenile neuronal ceroid lipofuscinosis (JNCL) or CLN3 disease (OMIM: 204200), is caused by mutations in the CLN3 gene on chromosome 16p12.1. Despite progress in the NCL field, the primary function of ceroid-lipofuscinosis neuronal protein 3 (CLN3) remains elusive. In this study, we aimed to clarify the role of human CLN3 in the brain by identifying CLN3-associated proteins using a Tandem Affinity Purification coupled to Mass Spectrometry (TAP-MS) strategy combined with Significance Analysis of Interactome (SAINT). Human SH-SY5Y-NTAP-CLN3 stable cells were used to isolate native protein complexes for subsequent TAP-MS. Bioinformatic analyses of isolated complexes yielded 58 CLN3 interacting partners (IP) including 42 novel CLN3 IP, as well as 16 CLN3 high confidence interacting partners (HCIP) previously identified in another high-throughput study by Behrends et al., 2010. Moreover, 31 IP of ceroid-lipofuscinosis neuronal protein 5 (CLN5) were identified (18 of which were in common with the CLN3 bait). Our findings support previously suggested involvement of CLN3 in transmembrane transport, lipid homeostasis and neuronal excitability, as well as link it to G-protein signaling and protein folding/sorting in the ER.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23464991     DOI: 10.1021/pr301125k

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  24 in total

1.  Proteomic and functional analyses in disease models reveal CLN5 protein involvement in mitochondrial dysfunction.

Authors:  Stefano Doccini; Federica Morani; Claudia Nesti; Francesco Pezzini; Giulio Calza; Rabah Soliymani; Giovanni Signore; Silvia Rocchiccioli; Katja M Kanninen; Mikko T Huuskonen; Marc H Baumann; Alessandro Simonati; Maciej M Lalowski; Filippo M Santorelli
Journal:  Cell Death Discov       Date:  2020-03-30

2.  Lysosomal Proteomics Links Disturbances in Lipid Homeostasis and Sphingolipid Metabolism to CLN5 Disease.

Authors:  Stefano Doccini; Maria Marchese; Federica Morani; Nicola Gammaldi; Serena Mero; Francesco Pezzini; Rabah Soliymani; Melissa Santi; Giovanni Signore; Asahi Ogi; Silvia Rocchiccioli; Katja M Kanninen; Alessandro Simonati; Maciej M Lalowski; Filippo M Santorelli
Journal:  Cells       Date:  2022-06-04       Impact factor: 7.666

Review 3.  Mass spectrometry-based proteomics in neurodegenerative lysosomal storage disorders.

Authors:  Wenping Li; Stephanie M Cologna
Journal:  Mol Omics       Date:  2022-05-11

4.  Transcriptomic Profiling Discloses Molecular and Cellular Events Related to Neuronal Differentiation in SH-SY5Y Neuroblastoma Cells.

Authors:  Francesco Pezzini; Laura Bettinetti; Francesca Di Leva; Marzia Bianchi; Elisa Zoratti; Rosalba Carrozzo; Filippo M Santorelli; Massimo Delledonne; Maciej Lalowski; Alessandro Simonati
Journal:  Cell Mol Neurobiol       Date:  2016-07-15       Impact factor: 5.046

5.  Proteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules.

Authors:  Saara Tikka; Evanthia Monogioudi; Athanasios Gotsopoulos; Rabah Soliymani; Francesco Pezzini; Enzo Scifo; Kristiina Uusi-Rauva; Jaana Tyynelä; Marc Baumann; Anu Jalanko; Alessandro Simonati; Maciej Lalowski
Journal:  Neuromolecular Med       Date:  2015-12-26       Impact factor: 3.843

6.  Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.

Authors:  Michael X Henderson; Gregory S Wirak; Yong-Quan Zhang; Feng Dai; Stephen D Ginsberg; Natalia Dolzhanskaya; John F Staropoli; Peter C G Nijssen; TuKiet T Lam; Amy F Roth; Nicholas G Davis; Glyn Dawson; Milen Velinov; Sreeganga S Chandra
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

Review 7.  A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis.

Authors:  I Basak; H E Wicky; K O McDonald; J B Xu; J E Palmer; H L Best; S Lefrancois; S Y Lee; L Schoderboeck; S M Hughes
Journal:  Cell Mol Life Sci       Date:  2021-04-01       Impact factor: 9.261

8.  Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.

Authors:  Yu Zhong; Kabhilan Mohan; Jinpeng Liu; Ahmad Al-Attar; Penghui Lin; Robert M Flight; Qiushi Sun; Marc O Warmoes; Rahul R Deshpande; Huijuan Liu; Kyung Sik Jung; Mihail I Mitov; Nianwei Lin; D Allan Butterfield; Shuyan Lu; Jinze Liu; Hunter N B Moseley; Teresa W M Fan; Mark E Kleinman; Qing Jun Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-25       Impact factor: 6.633

9.  Human iPSC models of neuronal ceroid lipofuscinosis capture distinct effects of TPP1 and CLN3 mutations on the endocytic pathway.

Authors:  Xenia Lojewski; John F Staropoli; Sunita Biswas-Legrand; Alexandra M Simas; Larissa Haliw; Martin K Selig; Scott H Coppel; Kendrick A Goss; Anton Petcherski; Uma Chandrachud; Steven D Sheridan; Diane Lucente; Katherine B Sims; James F Gusella; Dolan Sondhi; Ronald G Crystal; Peter Reinhardt; Jared Sterneckert; Hans Schöler; Stephen J Haggarty; Alexander Storch; Andreas Hermann; Susan L Cotman
Journal:  Hum Mol Genet       Date:  2013-11-23       Impact factor: 5.121

10.  CLN3, at the crossroads of endocytic trafficking.

Authors:  Susan L Cotman; Stéphane Lefrancois
Journal:  Neurosci Lett       Date:  2021-07-16       Impact factor: 3.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.